DR. MAGALI VAN DEN BERGH M.D. NPI 1568717544

NPI Details

DR. Magali Van Den Bergh, M.D. is a medical oncology internal medicine in Fort Myers, FL with 14 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Magali Van Den Bergh, M.D. NPI is 1568717544. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

14543 GLOBAL PKWY STE 110
FORT MYERS, FL
ZIP 33913-446
Phone: (239) 264-7026
Fax: (239) 567-3679

The NPI 1568717544 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Iron binding capacity (HCPCS:83550)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Magnesium level (HCPCS:83735)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood count, manual test (HCPCS:85044)
• Red blood count, automated test (HCPCS:85045)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Folic acid level, serum (HCPCS:82746)
• Automated urinalysis test (HCPCS:81003)
• Drawing of blood for a medical problem (HCPCS:99195)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Phosphate level (HCPCS:84100)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Uric acid level, blood (HCPCS:84550)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Erythropoietin (protein) level (HCPCS:82668)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 7/17/2012 and was last updated on 7/17/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.